- Home
- VIAV vs MLTX Comparison
VIAV vs MLTX Comparison
Compare VIAV & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIAV
- MLTX
- Stock Information
- Founded
- VIAV 1923
- MLTX 2021
- Country
- VIAV United States
- MLTX Switzerland
- Employees
- VIAV N/A
- MLTX N/A
- Industry
- VIAV Semiconductors
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- VIAV Technology
- MLTX Health Care
- Exchange
- VIAV Nasdaq
- MLTX Nasdaq
- Market Cap
- VIAV 2.2B
- MLTX 2.3B
- IPO Year
- VIAV 1993
- MLTX N/A
- Fundamental
- Price
- VIAV $9.86
- MLTX $38.33
- Analyst Decision
- VIAV Buy
- MLTX Strong Buy
- Analyst Count
- VIAV 8
- MLTX 8
- Target Price
- VIAV $12.94
- MLTX $80.50
- AVG Volume (30 Days)
- VIAV 2.1M
- MLTX 489.2K
- Earning Date
- VIAV 05-01-2025
- MLTX 05-06-2025
- Dividend Yield
- VIAV N/A
- MLTX N/A
- EPS Growth
- VIAV N/A
- MLTX N/A
- EPS
- VIAV N/A
- MLTX N/A
- Revenue
- VIAV $1,007,000,000.00
- MLTX N/A
- Revenue This Year
- VIAV $10.56
- MLTX $103.42
- Revenue Next Year
- VIAV $7.78
- MLTX N/A
- P/E Ratio
- VIAV N/A
- MLTX N/A
- Revenue Growth
- VIAV N/A
- MLTX N/A
- 52 Week Low
- VIAV $6.60
- MLTX $31.42
- 52 Week High
- VIAV $12.91
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- VIAV 36.77
- MLTX 51.82
- Support Level
- VIAV $9.72
- MLTX $31.90
- Resistance Level
- VIAV $10.27
- MLTX $37.73
- Average True Range (ATR)
- VIAV 0.51
- MLTX 2.99
- MACD
- VIAV -0.06
- MLTX 0.29
- Stochastic Oscillator
- VIAV 23.74
- MLTX 74.53
About VIAV Viavi Solutions Inc.
Viavi Solutions Inc. is a global provider of network test, monitoring and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of revenue from the United States.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.